Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.
Full text not available from this repository.| Item Type: | Monograph (Report) |
|---|---|
| Official URL: | http://www.imi-protect.eu/ |
| Additional Information: | © 2013 PROTECT Consortium |
| Divisions: | Management |
| Subjects: | H Social Sciences > HD Industries. Land use. Labor > HD61 Risk Management R Medicine > RS Pharmacy and materia medica R Medicine > RZ Other systems of medicine |
| Date Deposited: | 08 Dec 2015 17:05 |
| Last Modified: | 12 Dec 2024 06:01 |
| Projects: | Grant Agreement n° 115004, FP7/2007-2013 |
| Funders: | Innovative Medicines Initiative Joint Undertaking, European Union's Seventh Framework Programme, EFPIA |
| URI: | http://eprints.lse.ac.uk/id/eprint/64631 |
Actions (login required)
 |
View Item |
